The common ALL antigen (CALLA) i s a unique c e l l surface glycoprotein detected on t h e lymphoblasts of most cases of childhood ALL and some B c e l l tumors t o which Ritz e t a 1 (Nature =: 583, 1980) have generated a c y t o l y t i c monoclonal antibody (5-5). To determine whether J-5 i s distributed on t h e surfaces of hematopoietic progenitors and with t h e ultimate purpose of developing a useful approach t o autotransplantation, we t h r i c e exposed normal marrow and blood mononuclear c e l l s t o J-5 and complement a f t e r having determined t h a t such treatment i s s u f f i c i e n t t o eradicate >99% J-5" lymphoblasts. The c e l l s were then cultured i n both plasma c l o t and methylcellulose systems t o which were added appropriate inducers. Erythroid, granuloid and mixed erythroid/granuloid colony growth was unaffected both with r espect t o number, size, and morphology. The normal colonies were preserved even i n experiments i n which J-5+ leukemic c e l l s were added t o t h e normal marrows and lysed during antibody exposure. These r e s u l t s suggest t h a t CALLA i s absent from the surface of committed marrow and peripheral blood myeloid progenitors. The antibody is a powerful p o t e n t i a l tool f o r elimination of CALLA" lymphoblasts from marrow prior t o autologous bone marrow transplantation.
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VARIANT VON WILLEBRANO' S DISEASE (vWD): ABNORMALITY IN MULTIMERIC ASSEMBLY OF FACTOR VIII RELATED ANTIGEN
' ' 02 1VIIIRAa). Herbert A. Coowr. Marv A. Lamb. and Robert H. ~a g n e r . ijniv. of N, ~a r o l i n a , Ctr. +or ~hromb. and Hemostasis and Dept. of Pathology, Chapel Hill. Factor VIII in normal plasma i s a complex of a t l e a s t two molecules, VIIIRAg and VIIIC, each having d i s t i n c t functional and antigenic properties. VIIIRAg normally assembles as a s e r i e s of multimeric forms ranging from 1 t o >20x106 daltons. W e show, using a new crossed immunoelectrophoresis procedure, the importance of identifying a l t e r ations in the distribution of these multimeric forms. A normal distribution f o r a t l e a s t 5 d i s t i n c t forms of VIIIRAg was established using both pooled and individual plasmas. The slowest migrating form contained the most of the antigen while the four f a s t e r forms had progressively decreasing concentrations. Two patients presented a s possible vWD variants because of prolonged bleeding times and low r i s t o c e t i n cofactor a c t i v i t y despite normal t o elevated levels of VIIIRAg. Both plasmas showed e s s e n t i a l l y complete absence of the larger multimers and an absolute increase in t h e concentration of the anodal forms t h a t corresponded t o the f a s t e r migrating forms in normal plasma. An additional f a s t e r migrating form was found i n one of the plasmas. Patterns of cryosupernatant and commercial FVIII preparations were similar t o the variant patterns; cryoprecipitate resembled more closely t h e normal plasma pattern. Results suggest t h a t some types of vWD can r e s u l t from an abnormality in the a b i l i t y of VIIIRAg t o assemble i n t o the larger multimeric forms and supports the hypothesis t h a t the l a r g e s t forms of VIIIRAg a r e necessary f o r normai hemostasis through participation in platelet-vessel wall interactions.
EFFECT OF VITAMIN E ON CHRONIC HEMOLYSIS DUE TO IN-CREASED SENS IT
. Sheetz B. Shafer, and 2.E. m a n .
N IH, Bethesda; FiD a n d n i v . ~o n n . '~~r m i n g t o n , CT. Chronic hemolysis and increased s u s c e p t i b i l i t y t o oxidant s t r e s s occur in two hereditary disorders associated with defect i v e production of reduced glutathione: glutathione synthetase deficiency (GSD) and chronic hemolytic glucose 6-phosphate dehydrogenase deficiency (CHGCPD). High doses of d l , a-tocopheryl acetate (T), e s t e r of t h e antioxidant vitamin E, improved red c e l l survival i n a patient with each condition (Ann. Int. Med. 90:53, 1979) . Additional patients, 2 with GSD and 7 with CHG6PD T o m 3 kindreds, have now ingested 1000 I.U./day of T f o r a t l e a s t 6 months. One GSD patient was treated from b i r t h ; red c e l l half l i f e (RBCT50) a t age one yr. was 24.6d (normal = 25-28d) hemoglobin (Hgb) was 13.6gldl and reticulocyte count ( R C %~ was 0.92-2.3%.
An unrelated adult male GSD subject without oxoprolinuria had pretreatment RBCT50=8.5d increasing t o 14.ld a f t e r T; Hgb rose from 13.3g/dl t o 14.5g/dl a s RC% f e l l from 10.2 t o 3.8. Before T, t h e CHG6PD subjects had marked hemolysis: mean Hgb=12.7g/d1+.3SEM, RC%=14.1%+1.4, and RBCT50=6.6d+.7. Base1 ine mean plasma (870+116) and-red c e l l (307+21) a-tocopherol levels (pg/dl) were normaT before T and rose t o T793+398 and 563y08 respectively. These 7 CHG6PD subjects showez no improvement i n any hematologic parameter a f t e r T, and t h e i r high molecul a r weight erythrocyte membrane protein aggregates were a l s o unchanged. While T consistently ameliorates hemolysis i n GSD, most CHG6PD patients do not respond.
PLATELET ASSOCIATED IMMUNOGLOBULIN, PLATELET SIZE 804 AND THE EFFECT OF SPLENECTOMY IN THE WISKOTT-ALDRICH SYNDROME. Laurence Corash, Brenda Shafer, Wendell Rosse, and R. Michael Blaese, National I n s t i t u t e s of Health, Bethesda, Maryland.
Severe thrombocytopenia, characterized by small p l a t e l e t s , i s a major cause of morbidity and mortality in the Wiskott-Aldrich Syndrome (WAS). This microthrombocytopenia was assumed t o ref l e c t a primary defect i n p l a t e l e t production u n t i l t h e recent demonstration t h a t splenectomy (Spx) frequently normalizes the p l a t e l e t count. W e have measured p l a t e l e t mean volume (PMV) and p l a t e l e t associated immunoglobulin (PAIgG) in WAS patients before and a f t e r Spx. WAS p a t i e n t s (11.14) average MPV pre-Spx was 3.2 p3 5 .2 s.e.m. compared t o normal controls1 MPV of 6.6 p3 2 .6, p,.<001. 7 WAS patients underwent Spx, in each case a normal p l a t e l e t count was achieved and the group MPV rose t o 5.8 p3 +
.3, within t h e normal range. PAIgG per p l a t e l e t in the WAS subj e c t s (n.10) pre-Spx ranged from 18.1 f g t o 267.3 fg mean 78.9 fg + 23.3, s i g n i f i c a n t l y greater than normal (<4 fg/ p l a t e l e t ) and -a p l a s t i c controls, p<.001. In 5 WAS subjects studied post-Spx, PAIgG mean declined t o normal, ranging from 1.6 fg t o 8.7 fg, with a mean 4.0 f g 5 1.25. Increase in MPV and decrease in PAIgG usually occurred within two weeks of Spx. Based upon the ohanges in MPV and PAIgG, we speculate t h a t immune mediated p l a t e l e t destruction occurs i n WAS subjects, t h a t t h i s process requires an i n t a c t spleen and a complex interaction between t h e WAS IgGcoated p l a t e l e t and splenic macrophages resulting i n piecemeal l o s s of p l a t e l e t membrane giving r i s e t o t h e small WAS p l a t e l e t . The 4 non-responders did not have documented infections. Blood urea nitrogen, creatinine, creatinine clearance, potassium and urine analysis obtained before and a f t e r a n t i b i o t i c therapy showed no s i g n i f i c a n t differences. Comparisons of mean peak/ trough serum levels of Am obtained on day 2 (23.9/< 2pg/ml) and day 5 (24.2/< 2pg/ml) showed no accumulation. Two of 23 paired audiograms obtained early i n the course of and a f t e r Am therapy showed t r a n s i e n t m i l d high frequency hearing loss. Am and T i have low t o x i c i t y , a r e well tolerated and a r e adequate empiric therapy f o r the f e b r i l e neutropenic child. [1965] [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] [1975] . Forty (49%)children, including 18 males,remained i n complete continuous remission (CCR) a t 3 years. Between the t h i r d and f i f t h years o f therapy, 3 males and 3 females relapsed. The sites of i n i t i a l relapse were the CNS i n 5(4 had received CNS prophylaxis) and a simultaneous marrow and t e s t i c u l a r relapse i n the sixth. Five w e r e i n i t i a l l y high r i s k p a t i e n t s by age(<2 o r >8 years)or white count (~30,000/mm~) c r i t e r i a . One additional c h i l d died, i n remission, o f varicella complications. 33 p a t i e n t s (40%) remained i n CCR a t l e a s t 5 years. They had received chemotherapy for a median o f 61 mos. Followup times off therapy ranged from 6-178 mos (median 36+ mos). One boy i n t h i s group subsequently relapsed i n the marrow 16 months a f t e r therapy ended. W e conclude t h a t the relapse r a t e o f 17.5% (7/40) a f t e r 3 years o f CCR is comparable t o the 20% relapse rate reported by St. Jude Children's Research Hospital (NEJM 300:269, 1979) , although our p a t i e n t s received therapy f o r an additional 2+ years. Continuing therapy beyond 3 years would therefore s e e m t o subject p a t i e n t s t o continued potential morbidity without improving ultimate prognosis.
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